Elucidating mechanisms of genetic cross-disease associations: an integrative approach implicates protein C as a causal pathway in arterial and venous diseases
Authors:
- David StaceyDSDavid Stacey
- Lingyan ChenLCLingyan Chen
- Joanna M. M. HowsonJHJoanna M. M. Howson
- Amy M. MasonAMAmy M. Mason
- Stephen BurgessSBStephen Burgess
- Stephen MacDonaldSMStephen MacDonald
- Jonathan LangdownJLJonathan Langdown
- Kate DownesKDKate Downes
- Neda FarahiNFNeda Farahi
- James E. PetersJPJames E. Peters
- Saonli BasuSBSaonli Basu
Preprint
Abstract
Genome-wide association studies have identified many individual genetic loci associated with multiple complex traits and common diseases. There are, however, few examples where the molecular basis of such pleiotropy has been elucidated. To address this challenge, we describe an integrative approach, focusing on the p.Ser219Gly (rs867186 A>G) variant in the PROCR gene (encoding the endothelial protein C receptor, EPCR), which has been associated with lower coronary artery disease (CAD) risk but higher venous thromboembolism (VTE) risk. In a phenome scan of 12 cardiometabolic diseases and 24 molecular factors, we found that PROCR -219Gly associated with higher plasma levels of zymogenic and activated protein C as well as coagulation factor VII. Using statistical colocalization and Mendelian randomization analyses, we uncovered shared genetic etiology across activated protein C, factor VII, CAD and VTE, identifying p.S219G as the likely causal variant at the locus. In a recall-by-genotype study of 52 healthy volunteers stratified by p.S219G, we detected 2.5-fold higher soluble EPCR levels and 1.2-fold higher protein C levels in plasma per effect allele, suggesting the allele induces EPCR shedding from the membrane of endothelial cells. Finally, in cell adhesion assays, we found that increasing concentrations of activated protein C, but not soluble EPCR, reduced leukocyte–endothelial cell adhesion, a marker for vascular inflammation. These results support a role for protein C as a causal factor in arterial and venous diseases, suggesting that PROCR -219Gly protects against CAD through anti-inflammatory mechanisms while it promotes VTE risk through pro-thrombotic mechanisms. Overall, our study illustrates a multi-modal approach that can help reveal molecular underpinnings of cross-disease associations.Keywords
This publication has 79 references indexed in Scilit:
- A new, rapid and reproducible method to obtain high quality endothelium in vitroCytotechnology, 2012
- The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studiesBlood, 2012
- Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Inhibits Neutrophil Recruitment through an Interleukin-6-Dependent Mechanism: a New Paradigm for Viral Immune EvasionJournal of Virology, 2011
- A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) ConsortiumHuman Molecular Genetics, 2011
- Genetic Predictors of Fibrin D-Dimer Levels in Healthy AdultsCirculation, 2011
- Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC studyBlood, 2010
- Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand FactorCirculation, 2010
- PROC,PROCR andPROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health StudyJournal of Thrombosis and Haemostasis, 2008
- Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasmaBlood, 2008
- Endothelial Cell Protein C Receptor Acts as a Cellular Receptor for Factor VIIa on EndotheliumJournal of Biological Chemistry, 2007